{Reference Type}: Journal Article
{Title}: Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meeting.
{Author}: Wright BL;Abonia JP;Abud EM;Aceves SS;Ackerman SJ;Braskett M;Chang JW;Chehade M;Constantine GM;Davis CM;Dellon ES;Doyle AD;Durban R;Hill DA;Jensen ET;Kewalramani A;Khoury P;Klion AD;Kottyan L;Kuang FL;McGowan EC;Ruffner MA;Spencer LA;Spergel JM;Uchida AM;Wechsler JB;Pesek RD;
{Journal}: J Allergy Clin Immunol
{Volume}: 0
{Issue}: 0
{Year}: 2024 Aug 5
{Factor}: 14.29
{DOI}: 10.1016/j.jaci.2024.07.022
{Abstract}: The Consortium of Eosinophilic Gastrointestinal disease Researchers (CEGIR) and The International Gastrointestinal Eosinophil Researchers (TIGERs) organized a daylong symposium at the 2024 annual meeting of the American Academy of Allergy, Asthma & Immunology. The symposium featured new discoveries in basic and translational research as well as debates on the mechanisms and management of eosinophilic gastrointestinal diseases. Updates on recent clinical trials and consensus guidelines were also presented. We summarize the updates on eosinophilic gastrointestinal diseases presented at the symposium.